Research Developments in Atopic Dermatitis

Follow Research Developments in Atopic Dermatitis

Share on

Sep 8, 2020 LATEST EPISODE
infrequent NEW EPISODES
6m AVG DURATION
10 EPISODES

Search for episodes from Research Developments in Atopic Dermatitis with a specific topic:

Latest episodes from Research Developments in Atopic Dermatitis

Introduction and Overview

Play Episode Listen Later Sep 8, 2020 5:08

Welcome to this activity focusing on new research related to atopic dermatitis presented as posters at the 2020 virtual annual meetings of the American Academy of Dermatology and the American Academy of Allergy, Asthma, and Immunology. The posters focus on new data related to the use of advanced therapies for atopic dermatitis. Beyond discussing the methods and results of each poster, the faculty, Drs. Steven Feldman and Alan Fleischer, Jr., share their views on the implication of the trial results on clinical practice. They also discuss new evidence related to the burden of disease experienced by patients and caregivers and intriguing evidence pointing to the heterogeneity of atopic dermatitis.

american academy drs allergy asthma immunology dermatology

Efficacy and Safety Trends with Continuous Longterm Use of Crisaborole Ointment 2% in Patients with Mild-to-Moderate Atopic Dermatitis

Play Episode Listen Later Sep 8, 2020 6:59

The poster was presented by Dr. Lebwohl and colleagues at the 2020 American Academy of Dermatology virtual annual meeting. This audio commentary is provided by Dr. Steve Feldman.

safety patients long term american academy continuous mild moderate efficacy dermatology ointment atopic dermatitis steve feldman

Safety, Efficacy and Pharmacokinetics of Crisaborole Ointment 2% in Infants Age Three to Less Than 24 Months with Mild-to-Moderate Atopic Dermatitis

Play Episode Listen Later Sep 8, 2020 6:45

This poster was presented by Dr. Schlessinger and colleagues at the 2020 American Academy of Dermatology virtual annual meeting. This overview is provided by Dr. Steve Feldman.

safety american academy infants mild moderate efficacy dermatology ointment atopic dermatitis pharmacokinetics steve feldman schlessinger

Association Between an Itch-Free State in Atopic Dermatitis Treated with Ruxolitinib Cream and Systemic Inflammatory Mediators

Play Episode Listen Later Sep 8, 2020 4:43

This poster was presented by Dr. Owens and colleagues at the 2020 American Academy of Dermatology virtual annual meeting. This overview is provided by Dr. Steve Feldman.

cream american academy owens systemic treated itch dermatology inflammatory free state mediators atopic dermatitis steve feldman

Dupilumab Treatment for up to Three Years Demonstrates Sustained Efficacy in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from Liberty AD Adult Open Label Extension

Play Episode Listen Later Sep 8, 2020 5:17

This poster was presented by Dr. Blauvelt and colleagues at the 2020 American Academy of Dermatology virtual annual meeting. This over is provided by Dr. Steve Feldman.

treatments extension american academy severe moderate sustained efficacy dermatology demonstrates atopic dermatitis adult patients steve feldman

Patient-reported Outcome, or PROs, with Abrocitinib Treatment in Patients with Moderate to Severe Atopic Dermatitis

Play Episode Listen Later Sep 8, 2020 7:11

This poster was presented by Dr. Silverberg and colleagues at the 2020 American Academy of Dermatology virtual annual meeting. This overview is provided by Dr. Alan Fleischer.

patients treatments pros outcome american academy severe reported moderate dermatology silverberg atopic dermatitis

Peak Pruritus Numeric Rating Scale, the PPNRS, Response with Abrocitinib in Patients with Moderate to Severe Atopic Dermatitis: Results from a Randomized Phase 3 Clinical Trial

Play Episode Listen Later Sep 8, 2020 7:25

This poster was presented by Dr. Simpson and colleagues at the 2020 American Academy of Dermatology virtual annual meeting. This overview is provided by Dr. Alan Fleischer.

patients scale peak simpson american academy severe clinical trials moderate dermatology phase 3 randomized atopic dermatitis numeric pruritus

Dupilumab Treatment Results in Rapid Improvement in Itch in Adults and Adolescent Patients with Moderate to Severe Atopic Dermatitis

Play Episode Listen Later Sep 8, 2020 6:42

This poster was presented by Dr. Gil Yosipovitch and colleagues at the 2020 American Academy of Allergy, Asthma, and Immunology virtual annual meeting. This overview is provided by Dr. Alan Fleischer.

patients treatments adults rapid american academy severe allergy asthma moderate adolescent immunology itch atopic dermatitis

Treatment Patterns Among Patients with Atopic Dermatitis Using Advanced Therapies in the United States: An Analysis of a Retrospective Claims Database

Play Episode Listen Later Sep 8, 2020 6:01

This poster was presented by Dr. Larry Eichenfield and colleagues at the 2020 American Academy of Dermatology virtual annual meeting. This overview is provided by Dr. Alan Fleischer.

united states patients treatments patterns claims retrospective american academy databases therapies dermatology atopic dermatitis

Claim Research Developments in Atopic Dermatitis

In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

Claim Cancel